Concurrent Investment Advisors’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.3K Sell
12,651
-1,800
-12% -$3.38K ﹤0.01% 2076
2026
Q1
$12.9K Sell
14,451
-38,500
-73% -$36.4K ﹤0.01% 1917
2025
Q4
$53.5K Buy
52,951
+19,200
+57% +$23.8K ﹤0.01% 1740
2025
Q3
$45.2K Sell
33,751
-48,900
-59% -$51.9K ﹤0.01% 1452
2025
Q2
$65.3K Buy
+82,651
New +$97.8K ﹤0.01% 1344

Other funds holding IFRX

Concurrent Investment Advisors's IFRX Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its InflaRx (IFRX) stake by 12% in Q2 2026, selling an estimated $3.38K and leaving 12,651 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Concurrent Investment Advisors first reported a position in IFRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $65.3K in Q2 2025. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Concurrent Investment Advisors held 12,651 shares of InflaRx worth $28.3K as of Q2 2026.
  • Concurrent Investment Advisors sold 1,800 InflaRx shares in Q2 2026, an estimated $3.38K.
  • InflaRx made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #2076 holding.
  • Concurrent Investment Advisors first reported a position in InflaRx in Q2 2025 and has held it in 5 quarters since.
  • Concurrent Investment Advisors's InflaRx position peaked at $65.3K in Q2 2025.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.